A carregar...
Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
INTRODUCTION: In general, HIV co-infected patients included in clinical trials evaluating the hepatitis C virus (HCV) therapy with telaprevir (TVR) or boceprevir (BOC) with advanced fibrosis, are scarce. We analyze data concerning the use of these drugs in a real-life clinical setting with patients...
Na minha lista:
Publicado no: | J Int AIDS Soc |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
International AIDS Society
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224840/ https://ncbi.nlm.nih.gov/pubmed/25394138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19634 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|